Summary & Overview
HCPCS Q4203: Derma-gide Dermal Matrix, Per Square Centimeter
HCPCS Level II code Q4203 designates Derma-gide, a dermal matrix product billed per square centimeter as an add-on item to a primary surgical procedure. This code identifies use of a biologic or collagen scaffold applied during reconstructive or wound-repair procedures to support tissue regeneration. Nationally, accurate reporting of add-on product codes such as Q4203 affects product utilization tracking, payer coverage decisions, and aggregate spending on advanced wound and reconstructive materials.
Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical use and typical sites of service, common payer coverage considerations, and benchmarking topics relevant to supply and procedure line reporting. The publication summarizes how Q4203 is documented alongside primary procedures, highlights the role of per-unit (per square centimeter) billing for precise product accounting, and outlines which elements are commonly reviewed by payers for medical necessity and coding consistency.
The report is intended for billing managers, surgical providers, and policy analysts seeking a national perspective on coding practices, reimbursement patterns, and operational implications for dermal matrix products billed as add-ons.
Billing Code Overview
HCPCS Level II code Q4203 describes Derma-gide, billed per square centimeter as an add-on product that is listed separately in addition to a primary procedure. The service type is use of a dermatologic collagen or regenerative dermal matrix product for reconstructive or wound repair purposes. The typical site of service is operating room or outpatient surgical setting where a primary procedure addressing a skin defect, wound, or soft-tissue reconstruction is performed.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with a full-thickness skin defect after excision of a non-healing ulcer, traumatic wound, or resection of a skin malignancy requiring graft support. The patient presents to an outpatient surgical clinic or ambulatory surgery center for debridement and placement of a dermal substitute. Preoperative assessment includes wound measurement, infection control, and optimization of comorbidities such as diabetes or peripheral vascular disease. In the procedure suite under local, regional, or general anesthesia, the surgeon prepares the wound bed with sharp debridement and hemostasis, measures the defect in square centimeters, and applies the Derma-gide dermal matrix as an adjunct to primary repair or split-thickness skin grafting. The billed item Q4203 is reported per square centimeter as an add-on supply to the primary surgical procedure. Typical postoperative workflow includes dressing application, graft take assessment at post-op visits, wound care instructions, and monitoring for infection or graft failure. Usual sites of service are outpatient hospital departments, ambulatory surgery centers, and select office-based surgical suites.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work, time, or complexity substantially exceeds usual for the primary procedure when application materially increases complexity. |